At ASH 2025, investigators reported early results from the first-in-human phase 1 inMMyCAR study evaluating KLN-1010, an ...
SHANGHAI--(BUSINESS WIRE)--December 3rd, 2018, Shanghai, Generon BioMed Holding Ltd (Generon), announced today at the American Society of Hematology (ASH) Annual Meeting the pre-clinical study results ...
Patients with RRMM (≥ three prior lines including a proteasome inhibitor, an immunomodulatory drug, and an anti-CD38 monoclonal antibody) were eligible. ABBV-383 was administered intravenously over ...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) today announced safety and clinical response results from the ongoing Phase 1 study (NCT03269136) for PF-06863135, an investigational B-cell ...
Image of red blood cells and abnormal white blood cells in an acute lymphocytic leukemia cell blood smear, analyzed by microscope at 1000x magnification. T Cell Acute Lymphoblastic Leukemia (T-ALL) ...
T cell activation plays a key role in the immune response. Its activation, proliferation and differentiation necessitate dual stimulation signals. The initial signal is made up of a combination of TCR ...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech ...
An important step in the production of CAR-T cells is the evaluation of CAR expression. Usually, this is performed by flow cytometry using target antigens, protein L, or anti-Fab antibodies as ...
Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed? Patients with RRMM (≥ three prior lines including a proteasome inhibitor, an immunomodulatory drug, and an anti-CD38 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback